Phase 3 studies assessing XIAFLEX (collagenase clostridium histolyticum or CCH) for the treatment of Peyronie’s disease (PD) show this agent may significantly improve quality of life.
Injections with this agent appear to significantly improve penile curvature deformity and improve appearance and pain.
John Schieszer has the latest on the story in today’s Medical Minute.
Next post in The Medical Minute
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.